NO20014223L - Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer - Google Patents
Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomerInfo
- Publication number
- NO20014223L NO20014223L NO20014223A NO20014223A NO20014223L NO 20014223 L NO20014223 L NO 20014223L NO 20014223 A NO20014223 A NO 20014223A NO 20014223 A NO20014223 A NO 20014223A NO 20014223 L NO20014223 L NO 20014223L
- Authority
- NO
- Norway
- Prior art keywords
- diagnosis
- monitoring
- procedure
- breast carcinomas
- malignant breast
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/259,993 US6294349B1 (en) | 1999-03-01 | 1999-03-01 | Method of diagnosing and monitoring malignant breast carcinomas |
PCT/US2000/005364 WO2000052463A1 (en) | 1999-03-01 | 2000-03-01 | Method of diagnosing and monitoring malignant breast carcinomas |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014223D0 NO20014223D0 (no) | 2001-08-31 |
NO20014223L true NO20014223L (no) | 2001-10-23 |
Family
ID=22987369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014223A NO20014223L (no) | 1999-03-01 | 2001-08-31 | Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer |
Country Status (11)
Country | Link |
---|---|
US (3) | US6294349B1 (de) |
EP (1) | EP1161680A4 (de) |
JP (1) | JP2002538462A (de) |
CN (1) | CN1349611A (de) |
AU (1) | AU3613400A (de) |
BR (1) | BR0008709A (de) |
CA (1) | CA2363566A1 (de) |
HK (1) | HK1044816A1 (de) |
MX (1) | MXPA01008794A (de) |
NO (1) | NO20014223L (de) |
WO (1) | WO2000052463A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294349B1 (en) * | 1999-03-01 | 2001-09-25 | University Of Mississippi Medical Ctr. | Method of diagnosing and monitoring malignant breast carcinomas |
AU2003294206A1 (en) * | 2002-05-17 | 2004-04-19 | Eastern Virginia Medical School | Methods for diagnosing htlv-i-mediated diseases |
US20040033613A1 (en) * | 2002-05-30 | 2004-02-19 | Zwick Michael G. | Saliva-based protein profiling |
WO2005013804A2 (en) * | 2003-08-05 | 2005-02-17 | Euro-Celtique S.A. | ErbB RECEPTOR METHODS AND KITS FOR MONITORING CHEMOTHERAPY RESISTANCE |
US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
US20050112622A1 (en) | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
US20050106642A1 (en) * | 2003-11-19 | 2005-05-19 | Lipps Binie V. | Saliva test for early diagnosis of cancers |
US20050186215A1 (en) * | 2004-02-04 | 2005-08-25 | Kwok Tim T. | CUDR as biomarker for cancer progression and therapeutic response |
EP1730304B1 (de) * | 2004-02-20 | 2013-01-02 | The Regents of the University of California | Verfahren zur speichel-mrna-profilerstellung |
US7964408B1 (en) | 2004-05-13 | 2011-06-21 | University Of South Florida | Lysophospholipids as biomarkers of ovarian cancer |
EP1761648A1 (de) * | 2004-06-18 | 2007-03-14 | Roche Diagnostics GmbH | Verwendung von pdx1-protein als marker für brustkrebs |
US20060115827A1 (en) * | 2004-07-01 | 2006-06-01 | University Of Southern California | Genetic markers for predicting disease and treatment outcome |
US20080131916A1 (en) * | 2004-08-10 | 2008-06-05 | Ring Brian Z | Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy |
US7951529B2 (en) * | 2004-09-17 | 2011-05-31 | The Johns Hopkins University | Biomarkers for breast cancer |
WO2007086915A2 (en) * | 2005-05-12 | 2007-08-02 | Applied Genomics, Inc. | Reagents and methods for use in cancer diagnosis, classification and therapy |
EP1934373A4 (de) * | 2005-09-14 | 2009-04-29 | Univ California | Speichelprotein und -rna zum nachweis von brustkrebs |
KR100828539B1 (ko) * | 2005-09-20 | 2008-05-13 | 후지제롯쿠스 가부시끼가이샤 | 이차원 코드의 검출 방법, 검출 장치, 및 검출 프로그램을기억한 기억 매체 |
WO2007048107A2 (en) * | 2005-10-19 | 2007-04-26 | Heska Corporation | Proteomic profiling of mast cell tumors and related methods, proteins and nucleic acid molecules |
EP1946118A4 (de) * | 2005-11-10 | 2009-01-21 | Aurelium Biopharma Inc | Gewebediagnose für brustkrebs |
EP2010922B1 (de) | 2006-04-03 | 2012-06-27 | Oratel Diagnostics, LLC | Verfahren für endometriose-screening |
WO2008005469A2 (en) * | 2006-06-30 | 2008-01-10 | Schering Corporation | Igfbp2 biomarker |
WO2008088343A1 (en) * | 2007-01-19 | 2008-07-24 | Biophysical Corporation | Methods for individualized health assessment service |
WO2008124525A1 (en) * | 2007-04-03 | 2008-10-16 | Vanderbilt University | Nanoparticles with molecular recognition elements |
EP2201363A4 (de) * | 2007-09-18 | 2011-03-16 | Univ Texas | Nachweis von speichelproteinen mit sekundärmodulation zu duktalem karzinom in situ der brust |
CN101234026B (zh) * | 2008-03-07 | 2010-04-14 | 李立 | 一种乳腺病变定量化影像评价系统 |
WO2011133770A2 (en) * | 2010-04-21 | 2011-10-27 | Board Of Regents Of The University Of Texas System | Salivary protein markers for detection of breast cancer |
NZ608260A (en) | 2010-08-20 | 2015-03-27 | Oratel Diagnostics Llc | Estrous cycle monitoring by color response |
ES2679995T3 (es) | 2011-03-11 | 2018-09-03 | Vib Vzw | Moléculas y métodos para la inhibición y detección de proteínas |
WO2013009813A1 (en) | 2011-07-11 | 2013-01-17 | Oratel Diagnostics, Llc | Methods and kit for endometriosis diagnosis |
WO2013074793A1 (en) | 2011-11-15 | 2013-05-23 | University Of Miami | Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma |
CN104142397A (zh) * | 2014-08-06 | 2014-11-12 | 厦门大学 | 胸腺素alpha原在制备乳腺癌诊断标记物中的应用 |
JP7344631B2 (ja) * | 2015-02-09 | 2023-09-14 | アボゲン, インコーポレイティド | サンプル収集関連応用、分析および診断のためのデバイス、溶液および方法 |
JP2017211886A (ja) * | 2016-05-26 | 2017-11-30 | 株式会社ブラケアジェネティクス | 女性の健康増進に有用なカスタマイズ情報の提供システム |
WO2018098379A1 (en) * | 2016-11-22 | 2018-05-31 | Prime Genomics, Inc. | Methods for cancer detection |
MX2019013517A (es) | 2017-05-24 | 2020-08-17 | Pandion Operations Inc | Inmunotolerancia dirigida. |
CN111247432A (zh) * | 2017-10-16 | 2020-06-05 | 亨利技术有限公司 | 使用唾液的乳腺癌检测试剂盒及乳腺癌检测方法以及使用唾液的可孕期检测试剂盒及可孕期检测方法 |
KR102018171B1 (ko) * | 2017-10-16 | 2019-09-04 | 헨리기술 주식회사 | 타액을 이용한 유방암 감지 키트 및 이를 이용한 유방암 감지 방법 |
US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
US10174092B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
US11078256B2 (en) | 2018-06-26 | 2021-08-03 | The Board Of Regents Of The University Of Texas System | Methods and compositions for inhibiting cancer cell growth |
TW202110885A (zh) | 2019-05-20 | 2021-03-16 | 美商潘迪恩治療公司 | 靶向MAdCAM之免疫耐受性 |
CN110297082A (zh) * | 2019-06-12 | 2019-10-01 | 杭州启创生物技术有限公司 | 唾液尿酸等标志物特异性检测和诊断痛风的方法 |
EP4107187A4 (de) | 2020-02-21 | 2024-07-03 | Pandion Operations Inc | Gewebegezielte immuntoleranz mit einem cd39-effektor |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401638A (en) | 1986-06-04 | 1995-03-28 | Oncogene Science, Inc. | Detection and quantification of neu related proteins in the biological fluids of humans |
US5512657A (en) | 1988-12-12 | 1996-04-30 | Bainbridge Sciences, Inc. | Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases |
US5527676A (en) * | 1989-03-29 | 1996-06-18 | The Johns Hopkins University | Detection of loss of the wild-type P53 gene and kits therefor |
ES2166352T3 (es) * | 1989-08-04 | 2002-04-16 | Schering Ag | Dominio externo de c-erbb-2:gp75. |
EP0731712A4 (de) | 1993-10-29 | 2005-11-09 | Univ Boston | Physiologisch stabile butlersäurepräparate, und butlersäuresalze und -derivate als antineoplastische wirkstoff |
WO1996012187A1 (en) * | 1994-10-13 | 1996-04-25 | Horus Therapeutics, Inc. | Computer assisted methods for diagnosing diseases |
US5840889A (en) | 1996-04-19 | 1998-11-24 | The Board Of Regents Of The University Of Nebraska | Synthesis of estrogen-purine base and estrogen-mercapturate adducts and development of fluorescent probes and monoclonal antibodies to assay those adducts |
US5858683A (en) | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
US7393823B1 (en) | 1999-01-20 | 2008-07-01 | Oregon Health And Science University | HER-2 binding antagonists |
US6294349B1 (en) * | 1999-03-01 | 2001-09-25 | University Of Mississippi Medical Ctr. | Method of diagnosing and monitoring malignant breast carcinomas |
-
1999
- 1999-03-01 US US09/259,993 patent/US6294349B1/en not_active Expired - Lifetime
-
2000
- 2000-03-01 MX MXPA01008794A patent/MXPA01008794A/es unknown
- 2000-03-01 EP EP00914790A patent/EP1161680A4/de not_active Withdrawn
- 2000-03-01 BR BR0008709-2A patent/BR0008709A/pt not_active IP Right Cessation
- 2000-03-01 WO PCT/US2000/005364 patent/WO2000052463A1/en not_active Application Discontinuation
- 2000-03-01 US US09/914,501 patent/US6972180B1/en not_active Expired - Lifetime
- 2000-03-01 JP JP2000602625A patent/JP2002538462A/ja active Pending
- 2000-03-01 CA CA002363566A patent/CA2363566A1/en not_active Abandoned
- 2000-03-01 AU AU36134/00A patent/AU3613400A/en not_active Abandoned
- 2000-03-01 CN CN00806967A patent/CN1349611A/zh active Pending
-
2001
- 2001-08-31 NO NO20014223A patent/NO20014223L/no not_active Application Discontinuation
- 2001-09-25 US US09/962,477 patent/US6670141B2/en not_active Expired - Lifetime
-
2002
- 2002-06-12 HK HK02104412.0A patent/HK1044816A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NO20014223D0 (no) | 2001-08-31 |
WO2000052463A9 (en) | 2002-04-11 |
JP2002538462A (ja) | 2002-11-12 |
EP1161680A4 (de) | 2002-04-17 |
EP1161680A1 (de) | 2001-12-12 |
US20020015964A1 (en) | 2002-02-07 |
AU3613400A (en) | 2000-09-21 |
HK1044816A1 (zh) | 2002-11-01 |
US6670141B2 (en) | 2003-12-30 |
US6972180B1 (en) | 2005-12-06 |
CA2363566A1 (en) | 2000-09-08 |
CN1349611A (zh) | 2002-05-15 |
WO2000052463A1 (en) | 2000-09-08 |
MXPA01008794A (es) | 2003-07-28 |
US6294349B1 (en) | 2001-09-25 |
BR0008709A (pt) | 2001-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014223L (no) | Fremgangsmåte for diagnostisering og overvåkning av maligne brystkarsinomer | |
NO20030714L (no) | Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter | |
NO20016427L (no) | Blandinger og fremgangsmåter for behandling av diagnose av lungekreft | |
NO20013002D0 (no) | Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft | |
NO994932D0 (no) | Blandinger og fremgangsmaater for behandling og diagnose av brystkreft | |
FI19992398A (fi) | Menetelmä ja järjestely sydämen lyönnin tunnistamiseksi | |
NO20024972L (no) | Blandinger og fremgangsmater for terapi og diagnose av brystkreft | |
DE69906008D1 (de) | Blutdruckmessgerät | |
NO20022087D0 (no) | Fremgangsmåte for behandling av diabetes | |
AU5481699A (en) | Brassieres which facilitate the drainage of lymphatic fluid from the breast areaof the human female | |
NO990722D0 (no) | FremgangsmÕte for behandling av hjertesvikt | |
NO20014804D0 (no) | Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse | |
NO20012963L (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
IS5035A (is) | Aðferðir til varnar gegn brjóstakrabbameini | |
IL142340A0 (en) | Methods for identification, diagnosis, and treatment of breast cancer | |
NO20025594D0 (no) | Blandinger og fremgangsmåter for terapi og diagnose av brystkreft | |
IT1307016B1 (it) | Procedimento e dispositivo per la trasmissione di segnali numerici. | |
NO20014805D0 (no) | Blandinger og fremgangsmåter for behandling og diagnose av brystkreft | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
HK1044988A1 (zh) | 預告和/或診斷胃癌危險的方法 | |
DE50005957D1 (de) | Röntgenuntersuchungsausrüstung | |
ITMI991950A0 (it) | Procedimento per la sintesi del ritomavir | |
GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
TR199900070A3 (tr) | Naftiridonlarin ve ara baglarin hazirlanmasina yönelik islem. | |
ZA200108257B (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |